Shopping Cart
- Remove All
- Your shopping cart is currently empty
Description | Enavogliflozin (DWP-16001) is an orally available small molecule and sodium glucose transporter 2 inhibitor. |
In vitro | Enavogliflozin (DWP-16001), a best-in-class antidiabetic agent, functions as a selective and orally active sodium-glucose cotransporter-2 (SGLT-2) inhibitor, as supported by references [1][2][3]. |
Alias | DWP-16001 |
Molecular Weight | 446.92 |
Formula | C24H27ClO6 |
Cas No. | 1415472-28-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (223.75 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.